Top

Diabetology & Metabolic Syndrome

Published in:

Open Access 01-12-2011 | Research

Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats

Authors: Saad A Noeman, Hala E Hamooda, Amal A Baalash

Published in: Diabetology & Metabolic Syndrome | Issue 1/2011

Abstract

Background

Obesity has become a leading global health problem owing to its strong association with a high incidence of diseases.

Aim

To induce rat obesity using high fat diet (HFD) and to estimate oxidative stress markers in their liver, heart and kidney tissues in order to shed the light on the effect of obesity on these organs.

Materials and methods

Sixty white albino rats weighing 150-200 g were randomly divided into two equal groups; group I: received high fat diet for 16 weeks, and group II (control group): received only normal diet (rat chow) for 16 weeks. Blood samples were taken for measurement of lipid profile, tissue samples from liver, heart and kidney were taken for determination of malondialdehyde (MDA), protein carbonyl (PCO), reduced glutathione (GSH) levels, and the activities of glutathione S- transferase (GST) glutathione peroxidase (GPx), catalase (CAT) and paraoxonase1 (PON1) enzymes.

Results

Data showed that feeding HFD diet significantly increased final body weight and induced a state of dyslipideamia. Also our results showed a significant increase MDA and PCO levels in the hepatic, heart and renal tissues of obese rats, as well as a significant decrease in the activity of GST, GPx and PON 1 enzymes. On the other hand CAT enzyme activity showed significant decrease only in renal tissues of obese rats with non significant difference in hepatic and heart tissues. GSH levels showed significant decrease in both renal and hepatic tissues of obese animals and significant increase in their heart tissues. Correlation studies in obese animals showed a negative correlation between MDA and PCO tissue levels and the activities of GPx, GST and PON1 in all tissues and also with CAT enzyme activity in renal tissues. Also a negative correlation was detected between MDA & PCO tissues levels and GSH levels in both hepatic and renal tissues. While positive correlation was found between them and GSH levels in heart tissues.

Conclusion

High fat diet-induced obesity is accompanied by increased hepatic, heart, and renal tissues oxidative stress, which is characterized by reduction in the antioxidant enzymes activities and glutathione levels, that correlate with the increase in MDA and PCO levels in most tissues. This may probably contribute to the additional progression of obesity related problems.

Available only for authorised users

Haslam W, James P: "Obesity". Lancet. 2005, 366: 1197-1197. 10.1016/S0140-6736(05)67483-1.CrossRefPubMed

Diemen V, Trindade N, Trindade R: Experimental model to induce obesity in rats. Acta Cir Bras. 2006, 21: 425-425.

Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H: Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004, 37: 115-115. 10.1016/j.freeradbiomed.2004.04.001.CrossRefPubMed

Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Investig. 2004, 114: 1752-1761.PubMedCentralCrossRefPubMed

Reaven G, Abbasi F, McLaughlin T: Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004, 59: 207-207. 10.1210/rp.59.1.207.CrossRefPubMed

Valdecantos P, Matute P, Martínez A: Obesity and oxidative: role of antioxidants supplementation. Rev Invest Clin. 2009, 61: 127-127.PubMed

Mishra KP: Cell membrane oxidative damage induced by gamma-radiation and apoptotic sensitivity. J Environ Pathol Toxicol Oncol. 2004, 23: 61-66. 10.1615/JEnvPathToxOncol.v23.i1.60.CrossRefPubMed

Olusi SO: Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotecticve enzymes in humans. Int J Obes. 2002, 26: 1159-1159. 10.1038/sj.ijo.0802066.CrossRef

Uzun H, Konukoglu D, Gelisgen R, Zengin K, Taskin M: Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg. 2007, 17 (10): 1367-1373. 10.1007/s11695-007-9242-8.CrossRefPubMed

10.

Blokhina O, Virolainen E, Fagerstedt KV: Antioxidants, Oxidative Damage and Oxygen Deprivation Stress a Review. Ann Bot. 2002, 91: 179-179.CrossRef

11.

Sentí M, Tomás M, Fitó M, Weinbrenner T, Covas M, Sala J, Masiá R, Marrugat J: Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol & Metab. 2003, 88: 5422-5426. 10.1210/jc.2003-030648.CrossRef

12.

Vincent HK, Taylor AG: Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2006, 30: 400-400. 10.1038/sj.ijo.0803177.CrossRef

13.

Xavier Pi-Sunyer F: The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002, 10: 97S-104S.CrossRefPubMed

14.

Musaad S, Haynes EN: Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev. 2007, 29: 98-114. 10.1093/epirev/mxm005.CrossRefPubMed

15.

Lavie CJ, Artham SM, Milani RV, Ventura HO: The obesity paradox: impact of obesity on the prevalence prognosis of cardiovascular diseases. Postgrad Med. 2008, 120: 34-34. 10.3810/pgm.2008.07.1788.CrossRefPubMed

16.

Kim JH, Hahm DH, Yang DC, Kim JH, Lee HJ, Shim I: Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J Pharmacol Sci. 2005, 97: 124-124. 10.1254/jphs.FP0040184.CrossRefPubMed

17.

Deeg R, Ziegenohrm J: Kinetic enzymatic method for automated determination of total cholesterol in serum. Clin Chem. 1983, 29 (10): 1798-1802.PubMed

18.

Fossati P, Prencipe L: Serum triglycerides determined colourmetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28 (1): 2077-2080.PubMed

19.

Friede WT, Levy RT, Fredrickson DF: Estimation of the concentration of Low Density Lipoprotein Cholesterol in plasma without use of the preparation ultra centrifuge. Ann Chem. 1972, 18: 499-499.

20.

Burestin M, Selvenick HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Lipid Res. 1970, 11: 583-583.

21.

Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMed

22.

Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979, 95: 351-351. 10.1016/0003-2697(79)90738-3.CrossRefPubMed

23.

Levine R, Garland D, Oliver C: Determination of carbonyl content of oxidatively modified proteins. Methods Enzymal. 1990, 186: 464-464.CrossRef

24.

Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233: 357-357.CrossRefPubMed

25.

Tietez F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969, 27: 502-502. 10.1016/0003-2697(69)90064-5.CrossRef

26.

Habig WH, Pabst MJ, Jacob WB: Glutathione S-transferase, the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249: 7130-7139.PubMed

27.

Chiu DT, Stults FH, Tappel AL: Purification and properties of rat lung soluble glutathione peroxidase. Biochim Biophys Act. 1976, 445: 558-558.CrossRef

28.

Sinha KA: Colorimetric assay of catalase. Anal Biochem. 1972, 47: 389-389. 10.1016/0003-2697(72)90132-7.CrossRefPubMed

29.

McElveen J, Mackness MI, Colley CM, Peard T, Warner S, Walker CH: Distribution of Paraoxon Hydrolytic Activity in the Serum of Patients after Myocardial Infarction. Clin Chem. 1986, 32: 671-671.PubMed

30.

Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG: Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes. 2004, 28: S58-S65.CrossRef

31.

Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Weiner R, Widhalm K: Interdisciplinary European guidelines on surgery for severe obesity. Rozhl Chir. 2008, 87: 468-468.PubMed

32.

Pagotto U, Vanuzzo D, Vicennati V, Pasquali RG: Pharmacological therapy of obesity. G Ital Cardiol (Rome). 2008, 9 (4 Suppl1): 835-935.

33.

Marović D: Elevated body mass index fatty liver. Srp Arh Celok Lek. 2008, 136: 122-125. 10.2298/SARH0804122M.CrossRefPubMed

34.

Lopez IP, Marti A, Milagro FI, Zulet Md Mde L, Moreno-Aliaga MJ, Martinez A, De Miguel C: DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res. 2003, 11: 188-188. 10.1038/oby.2003.30.CrossRefPubMed

35.

Diniz YS, Faine LA, Galhardi CM, Rodrigues HG, Ebaid GX, Burneiko RC, Cicogna AC, Novelli EL: Monosodium glutamate in standard and high-fiber diets. Metabolic syndrome and oxidative stress in rats. Nutrition. 2005, 21: 749-749. 10.1016/j.nut.2004.10.013.CrossRefPubMed

36.

Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC: Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006, 36: 485-485. 10.1677/jme.1.01909.CrossRefPubMed

37.

Milagro FI, Campión J, Martínez AJ: Weight Gain Induced by High-Fat Feeding Involves Increased Liver Oxidative Stress. Obesity. 2006, 14: 1118-1118. 10.1038/oby.2006.128.CrossRefPubMed

38.

Mercer1 JG, Archer ZA: Diet-induced obesity in the Sprague-Dawley rat: dietary manipulations and their effect on hypothalamic neuropeptide energy balance systems. Biochem Soc Transact. 2005, 33: 1086-1086.

39.

Woo MN, Bok SH, Lee MK, Kim HJ, Jeon SM, Do GM, Shin SK, Ha TY, Choi MS: Anti-obesity hypolipidemic effects of a proprietary herb fiber combination (S&S PWH) in rats fed high-fat diets. J Med Food. 2008, 11: 169-78. 10.1089/jmf.2007.082.CrossRefPubMed

40.

Kamal AA, Mohamed AN: Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabet & Metab Synd. 2009, 1: 1-17. 10.1186/1758-5996-1-1.CrossRef

41.

Grundy SM: Metabolic complications of obesity. Obesity, Metabolic Syndrome, and Cardiovascular Disease. J Clin Endo & Metab. 2004, 89 (6): 2595-2600. 10.1210/jc.2004-0372.CrossRef

42.

Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand O, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardio metabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28: 1039-1039. 10.1161/ATVBAHA.107.159228.CrossRefPubMed

43.

Satoh N, Wada H, Ono K, Yamakage H, Yamada K, Nakano T, Hattori M, Shimatsu A, Kuzuya H, Hasegawa K: Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemi a in metabolic syndrome. Circ J. 2008, 72: 932-939. 10.1253/circj.72.932.CrossRefPubMed

44.

Leopold JA, Loscalzo J: Oxidative mechanisms and athero-thrombotic cardiovascular disease. Drug Discov. 2008, 5: 5-5.

45.

Keaney JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, et al: Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol. 2003, 23: 434-434. 10.1161/01.ATV.0000058402.34138.11.CrossRefPubMed

46.

Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M: Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women. ARYA Atherosclerosis Journal. 2007, 2 (4): 189-192.

47.

Vincent HK, Powers SK, Dirks AJ, Scarpace P: Mechanism for obesity-induced increase in myocardial lipid per-oxidation. Int J Obes. 2001, 25: 378-378. 10.1038/sj.ijo.0801536.CrossRef

48.

Lachieitner M, Koch T, Harold M, Dzien A, Hoppiahler F: Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med. 2000, 248: 67-67. 10.1046/j.1365-2796.2000.00705.x.CrossRef

49.

Hafize U, Dildar K, Remisa G, Kagan Z, Mustafa T: Plasma Protein Carbonyl and Thiol Stress Before and After Laparoscopic Gastric Banding in Morbidly Obese Patients. Obesity Surgery. 2007, 17 (10): 1367-1373. 10.1007/s11695-007-9242-8.CrossRef

50.

Moya ET, Perez YG, Fiol M, Magdalena Gianotti M, Lladó I, Ana Proenza AM: Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress. Obesity. 2008, 16 (10): 2232-2238. 10.1038/oby.2008.340.CrossRef

51.

Carmiel-Haggai M, Nieto N: A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005, 19: 136-136.PubMed

52.

Esterbauer H, Gebicki J, Puhl H, Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol Med. 1992, 13: 341-341. 10.1016/0891-5849(92)90181-F.CrossRef

53.

Ji LL: Exercise and oxidative stress: role of the cellular antioxidant systems. Exercise Sport Sci Rev. 1995, 23: 135-166.CrossRef

54.

Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D: Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet. J Am Soc Nephrol. 2007, 18: 2715-2715. 10.1681/ASN.2007010089.CrossRefPubMed

55.

Lannaud-Bournoville M, Conti M, Bazin R, Michel O, Bariéty J, Chevalier J, Myara I: Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant. 1999, 15 (4): 467-476.

56.

Demori I, Voci A, Fugassa E, Burlando B: Combined effects of high-fat diet and ethanol induce oxidative stress in rat liver. Alcohol. 2006, 40: 185-185. 10.1016/j.alcohol.2006.12.006.CrossRefPubMed

57.

Rozenberg O, Aviram M: Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun. 2006, 351 (2): 492-498. 10.1016/j.bbrc.2006.10.059.CrossRefPubMed

Title: Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats
Authors: Saad A Noeman
Hala E Hamooda
Amal A Baalash
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Diabetology & Metabolic Syndrome / Issue 1/2011
Electronic ISSN: 1758-5996
DOI: https://doi.org/10.1186/1758-5996-3-17

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats

Abstract

Background

Aim

Materials and methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Aim

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2011

Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone

The macrophage at the intersection of immunity and metabolism in obesity

Mechanism of the mitogenic influence of hyperinsulinemia

Accuracy of a Novel Non-Invasive technology based EZSCAN system for the diagnosis of diabetes mellitus in Chinese

Current european regulatory perspectives on insulin analogues

Different exercise protocols improve metabolic syndrome markers, tissue triglycerides content and antioxidant status in rats

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page